Date: 2018-09-27

Type of information: Resignation

Compound: chief medical officer

Company: Editas Medicine (USA - MA)

Therapeutic area: Rare diseases - Genetic diseases - Ophtalmological diseases

Type agreement: resignation

Action mechanism:



  • • On August 27, 2018, Editas Medicine announced that its Chief Medical Officer, Gerald Cox will be stepping down from the company at the end of the year. A search is underway to find a successor to Dr. Cox, and the company continues to execute on its near-term and long-term goals of advancing transformative genomic medicines.

Financial terms:

Latest news:

Is general: Yes